Cromos Pharma, where the patients are

Global News

Kythera acquires ATX-101 rights from Bayer Consumer Care

Thursday, March 13, 2014 12:05 PM

Kythera Biopharmaceuticals has acquired all rights outside of the U.S. and Canada to ATX-101, a proprietary formulation of a purified synthetic version of deoxycholic acid currently in late-stage development for the reduction of submental fat (double chin). In 2010, Kythera licensed the commercial rights to ATX-101 outside of the U.S. and Canada to Bayer Consumer Care.

More... »

CRF Health eCOA webinar series

Infinity appoints Baselga, Berkowitz to board of directors

Thursday, March 13, 2014 11:26 AM

Infinity Pharmaceuticals has appointed José Baselga M.D., Ph.D., and Jeff Berkowitz as independent members of its board of directors. Baselga, physician-in-chief at Memorial Sloan-Kettering Cancer Center, is an accomplished clinician and a thought leader in the PI3K field. Berkowitz, as the president of Walgreens Boots Alliance Development in Europe, has experience in pharmaceuticals, pharmacy, distribution and market access, pricing and reimbursement.

More... »


Theorem Clinical Research recognized in 2014 CRO Leadership Awards

Thursday, March 13, 2014 11:10 AM

Theorem Clinical Research has won recognition in all five categories of the 2014 CRO Leadership Awards: Quality, Productivity, Reliability, Innovation and Regulatory.

More... »

Charles River Laboratories to acquire CRO services division of Galapagos

Thursday, March 13, 2014 10:40 AM

Massachusetts-based CRO Charles River Laboratories (CRL) has agreed to acquire the CRO services division of Galapagos, which includes both Argenta and BioFocus, for approximately $179 million.

More... »

Synergistix launches CATS Express mobile CRM solution

Wednesday, March 12, 2014 02:59 PM

Synergistix, a provider of customer relationship management (CRM) solutions for life sciences, has launched the newest member of its Customer Analysis and Targeting System (CATS) Software Suite: CATS Express, a smartphone version of the company’s CRM solution.

More... »

Almac expands Asia Pacific operations

Wednesday, March 12, 2014 02:58 PM

Global CDMO Almac has expanded its clinical services and technologies capabilities in Asia. The company has established regional hubs in Singapore and Japan to better enable the industry’s growing need to conduct clinical trials in Asia and manage global trials from the region. Local teams will design, implement and manage drug supply strategies and efficient technology solutions throughout the life of each study. 

More... »

Scripps Wellderly genome resource now available to researchers

Wednesday, March 12, 2014 02:56 PM

Scientists exploring the genetic causes of illnesses such as Alzheimer's disease, heart disease, cancer and diabetes now have a new tool—a reference DNA dataset built by researchers at Scripps Translational Science Institute (STSI). The Scripps Wellderly Genome Resource (SWGR) is comprised of the whole genome sequences of 454 participants in the Wellderly Study, an ongoing STSI research project that is searching for the genetic secrets behind lifelong health by looking at the genes of healthy elderly people.

More... »

UCB, Sanofi partner for immune-mediated diseases innovation

Wednesday, March 12, 2014 01:47 PM

UCB, a global biopharmaceutical company focused on the discovery and development of medicines for the immune system and central nervous system, and Sanofi, an integrated global healthcare provider, have entered a scientific and strategic collaboration for the discovery and development of innovative anti-inflammatory small molecules, which have the potential to treat immune-mediated diseases in areas such as gastroenterology and arthritis.

More... »

DPx launched by JLL Partners, Royal DSM

Wednesday, March 12, 2014 01:43 PM

JLL Partners and Royal DSM have launched DPx Holdings, a global contract development and manufacturing organization (CDMO) for the pharmaceutical and related industries.

More... »

Water Street, JLL complete merger of CCBR-SYNARC, BioClinica

Wednesday, March 12, 2014 01:37 PM

Water Street Healthcare Partners, a strategic investor focused exclusively on the healthcare industry, and JLL Partners, a middle-market private equity firm, have merged their companies CCBR-SYNARC and BioClinica. The combination creates a global provider of specialty outsourced clinical services.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs